Management of Carbapenem Resistant Gram-Negative Infections

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Rising carbapenem usage in India is linked to increasing resistance in gram-negative bacteria.
• Resistance mechanisms are often enzyme-mediated and plasmid-borne, facilitating horizontal transmission.
• Risk factors for infection include invasive procedures, prior antibiotic exposure, hospitalization, ICU stays, and illness severity.

Purpose of the Study:

• To review the current landscape of carbapenem resistance in gram-negative bacteria in India.
• To highlight the importance of differentiating colonization from infection for effective treatment.
• To discuss evolving treatment strategies, including the role of novel beta-lactam/beta-lactamase inhibitors.

Main Methods:

• Review of existing literature on carbapenem resistance in gram-negative bacteria.
• Analysis of risk factors associated with infections.
• Comparison of treatment approaches for carbapenem-resistant Enterobacterales and non-Enterobacterales.

Main Results:

• Carbapenem resistance is a growing concern in India, driven by factors like increased antibiotic use.
• Distinguishing colonization from infection and employing rapid diagnostics are critical for patient outcomes.
• Novel beta-lactam/beta-lactamase inhibitors show promise over polymyxins for managing these infections.

Conclusions:

• Effective management requires early, targeted therapy and consideration of novel therapeutic agents.
• Tailored treatment strategies for different resistant bacterial groups are essential.
• Infection control and antimicrobial stewardship are paramount in combating resistance.